Expansion of IMBRUVICA® (ibrutinib) Label in the U.S.

Expansion of IMBRUVICA® (ibrutinib) Label in the U.S.

U.S. Food and Drug Administration (FDA) Approves a Label Expansion for IMBRUVICA® (ibrutinib)  On February 26th, Johnson & Johnson, in collaboration with its alliance partner, Pharmacyclics LLC, an AbbVie Company, announced that the U.S. Food and Drug...
Holiday Self-Care: Being Present with Lita Artis

Holiday Self-Care: Being Present with Lita Artis

Holiday Self-Care with Lita Artis Thursday, December 19th 1pm ET Give yourself the gift of presence during this busy time of year! Join Lita Artis, massage therapist and Waldenstrom’s macroglobulinemia (WM) caregiver, to find peace and calm in the body and mind....
Make YOUR Voice Heard with the WM-VOICE Study

Make YOUR Voice Heard with the WM-VOICE Study

WM-VOICE study: Patient preferences on treatment options for Waldenström macroglobulinemia: An international discrete choice experiment. Study details: The WM-VOICE study is scientific research about Waldenström macroglobulinemia (WM). The study focuses on what...
Waldenström Finland Summer Summit 2024 – Helsinki

Waldenström Finland Summer Summit 2024 – Helsinki

Waldenström Finland Summer Summit 2024 – Helsinki By Jukka Sneck, Waldenström Finland From IWMF Torch October 2024 We had our annual face-to-face meeting on Saturday, August 24. The meeting took the whole day. Our association was founded five years ago, and this was...
IWMF Commits To Largest Research Package Since Inception!

IWMF Commits To Largest Research Package Since Inception!

IWMF Commits to Largest Research Package Since Inception! From IWMF Torch, October 2024 IWMF is making outstanding progress in the search for a cure. “Once we do a better job at shutting down the signaling of that mutated MYD88 gene, we will find that cure,” says Dr....
A Journey of Resilience: A 31-Year Battle with WM

A Journey of Resilience: A 31-Year Battle with WM

A Journey Of Resilience: A 31-Year Battle with WM By Art Brewerfrom the IWMF Torch, October 2024     On January 1993, Catherine Callahan received a diagnosis of Waldenstrom’s macroglobulinemia (WM) that would change her life. At the time, the prognosis for...
Integrative Oncology and Its Role  in Cancer Care

Integrative Oncology and Its Role in Cancer Care

Integrative Oncology and Its Role in Cancer Care By Stacy D’Andre, MD, Department of Medical Oncology, Mayo Clinic, Rochester, MN What is integrative oncology? Integrative oncology (IO) is a patient-centered, evidence-informed field of cancer care that utilizes mind...
WM-NET Update: New Venues and Trials

WM-NET Update: New Venues and Trials

From the IWMF Torch – October 2024 The new WM-NET clinical trials network continues to play an important role in fulfilling Dr. Treon’s prediction, that a cure is in sight, with the exciting news that more centers have been added to the initial list of 15...
NEW Updated IWMF FAQs Booklet

NEW Updated IWMF FAQs Booklet

NOW Available! Our Updated FAQs Booklet   Our popular Frequently Asked Questions (FAQ) booklet has been updated to include the most current information available on WM to support newly diagnosed and veteran patients with WM and their caregivers, family, and...